Navigation Links
Mayo Clinic's Dr. Denis Cortese Receives NCHL'S 2009 National Healthcare Leadership Award
Date:7/16/2009

NCHL, the leading authority on healthcare leadership, is pleased to honor Dr. Denis Cortese as the recipient of the 2009 National Healthcare Leadership Award for his lasting contributions to healthcare and his commitment to teamwork and mentorship during his 30-year career. Dr. Cortese is widely respected for his outspoken role in the national healthcare reform debate and for advocating for a system that ensures that all patients will receive outstanding and quality care.

CHICAGO, IL (PRWEB) July 16, 2009 -- The National Center for Healthcare Leadership (NCHL) said today it has named Denis A. Cortese, MD, president and chief executive officer of Mayo Clinic, as the recipient of the 2009 National Healthcare Leadership Award for his significant and lasting contributions to healthcare.

"Renowned for his commitment to teamwork and mentorship at one of the nation's premier healthcare organizations, Denis Cortese is also applying his leadership to impact the national healthcare agenda by building nationwide consensus for patient-centered change, advocating for a system that ensures that all patients will receive outstanding quality care," NCHL President and CEO Marie E. Sinioris said. "As an extraordinary leader and teacher, his innovative tenure at Mayo Clinic has included cutting edge programs in information technology and medical records, using new discoveries in genomics to customize patient-specific treatment strategies, and emphasis on bedside nursing to improve patient care. And under Dr. Cortese's leadership, Mayo Clinic launched the Health Policy Center, attracting thousands of patients and prominent thought leaders from across the nation to participate in a series of events to develop principles and action steps to guide healthcare reform."

Dr. Cortese will be honored on Wednesday, November 4, 2009 at an award event and recognition dinner at The Millennium Knickerbocker in Chicago that is being held in conjunction with NCHL's Invitational Symposium earlier that day. Dr. Cortese will be presented with an original glass sculpture by Czech-born artist Martin Rosol.

"The role for leadership in U.S. health care is wide open," Cortese said. "Leadership is less about 'you' or 'me' and more about us; what we can accomplish by working together. And much needs to be done to assure quality, affordable healthcare for all patients."

Thomas M. Priselac, president and CEO of Cedars-Sinai Health System and co-chair of the National Healthcare Leadership Award selection committee, praised Dr. Cortese's commitment to improving the nation's health. "During Dr. Cortese's career he has mirrored the vision of NCHL and used his unique ability to build consensus as he has advocated for a system of evidence-based, affordable, and accessible patient care for all," Priselac said. "The selection committee was honored to identify Dr. Cortese as this year's recipient and recognize his role as a forward thinking leader in national healthcare reform."

After serving as a Lieutenant Commander in the Medical Corps of the U.S. Navy, Cortese joined the Mayo Clinic staff in 1976 where he has been a professor of medicine and served as a former director of the Pulmonary Disease subspecialty training program. In 1993 he moved to Mayo Clinic in Jackson, Florida and in 2003 he was named CEO of Mayo Clinic in Rochester, Minnesota.

Dr. Cortese graduated from Temple University Medical School in 1970. He completed his internship and internal medicine residency at the Mayo Graduate School of Medicine. At Mayo Clinic he held a fellowship in thoracic diseases and was a special clinical fellow in bronchoscopy.

Widely published and the recipient of numerous honors and awards, Dr. Cortese is a member of The Institute of Medicine and chair of the Roundtable on Evidence-Based Medicine; Healthcare Leadership Council; Harvard/Kennedy Healthcare Policy Group; FRESH-Thinking; Advisory Board; World Community Grid; Academia Nacional de Medicine (Mexico); and the Royal College of Physicians (London).

Fawn Lopez, publisher of Modern Healthcare, which is co-sponsor of the NCHL National Healthcare Leadership Award, cited Dr. Cortese's many contributions to the field. "He has worked tirelessly and effectively to assert his leadership and influence to help frame the dialogue toward national healthcare reform. He sets a prime example for others to follow."

About National Center for Healthcare Leadership
The National Center for Healthcare Leadership (NCHL) is a not-for-profit organization that is an industry catalyst to assure the availability of accountable and transformational healthcare leadership for the 21st century. Its vision is to optimize the health of the public through leadership and organizational excellence. As the authoritative and objective source on healthcare leadership, NCHL conducts research on global best practices and tests new models for leadership excellence within its Leadership Excellence Networks (LENS). It provides innovative leadership development programs through the NCHL and GE Institute for Transformational Leadership.

# # #

Read the full story at http://www.prweb.com/releases/2009/07/prweb2639244.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Diplomat Specialty Pharmacy Expands National Growth Hormone Patient Care Program - Hires Denise Piro, RN, BSN
2. Medical Tactile, Inc. Announces Appointment of Denis A. OConnor as CEO & Member of Board of Directors
3. Size Does Matter ... and So Does Shape ... When It Comes to Teeth, Says Cosmetic Dentist, Dr. Denise Fundora
4. Todays Working Adults Face Long Term Care Double Whammy, Says Denise Gott, Spokesperson for LTC Financial Partners, LLC
5. PharmMD Announces Denise Kehoe as Vice President of Business Development
6. Komen for the Cure Central New Mexico Affiliate, Lt. Gov. Diane Denish, Sen. Dede Feldman, Breast Cancer Survivors Call on Elected Officials to Close the Gap in Access to Breast Health Services
7. Sysmex America Receives Highest Vendor Designation from MedAssets Supply Chain Systems
8. K-State scientist receives grant from National Institutes of Health to research cataracts
9. Wyeths Prevenar 13* Receives First Approval
10. Watson Pharmaceuticals Receives a Complete Response Letter for Its 24-Week Formulation of TRELSTAR(R) (triptorelin pamoate) NDA from US FDA
11. Bausch & Lomb Receives Approval of Crystalens HD in Quarter Diopter Steps
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mayo Clinic's Dr. Denis Cortese Receives NCHL'S 2009 National Healthcare Leadership Award
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
(Date:6/24/2016)... ... 24, 2016 , ... National recruitment firm Slone Partners is pleased ... and genomics experience, as Vice President of North American Capital Sales at HTG ... leading the sales team in the commercialization of the HTG EdgeSeq system and associated ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... June 24, 2016 ... announced the addition of the " Global Markets ... This report focuses ... an updated review, including its applications in various applications. ... market, which includes three main industries: pharmaceutical and biotechnology, ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology: